EcoDrugPlus

Transcription Factor P65-Like

Ensembl ID : ENSBSLG00000022881
Gene Symbol: LOC114851349
3 Cross references
201 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSBSLG00000001215
Gene Symbol: TGFBR1B
1 Cross references
166 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSBSLG00000017465
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSBSLG00000000938
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSBSLG00000019829
Gene Symbol: TUBA4A
3 Cross references
158 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSBSLG00000010057
Gene Symbol: LOC114869453
2 Cross references
160 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSBSLG00000001877
Gene Symbol: LOC114844824
2 Cross references
144 Possible Orthologues:

Tubulin Alpha-1b Chain-Like

Ensembl ID : ENSBSLG00000009534
Gene Symbol: LOC114850088
2 Cross references
178 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSBSLG00000009988
Gene Symbol: LOC114842938
3 Cross references
114 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSBSLG00000025735
Gene Symbol: LOC114855083
2 Cross references
184 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSBSLG00000025961
Gene Symbol: LOC114844017
3 Cross references
301 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSBSLG00000012458
Gene Symbol: LOC114864431
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).